Reuters Health Report

Click to View in Browser 02/6/2014 Big Pharma pushes for U.S. action against India over patent worries MUMBAI/LONDON (Reuters) - Global pharmaceutical firms are pressuring the United States to act against India to stop more local companies producing up to a dozen new varieties of cheap generic drugs still on-patent, sources with direct knowledge of the matter said. Americans need to eat more whole grains, study suggests NEW YORK (Reuters Health) - Most children and adults in the U.S. are getting less than the recommended amounts of whole grains and dietary fiber, according to a recent study. And the ayes have it, or were they just louder? NEW YORK (Reuters Health) - A single shouter can taint the outcome of a voice vote, a procedure legislative bodies regularly employ to determine public policy, new research shows. Kids learn to shoot down stroke with video game NEW YORK (Reuters Health) - A doctor who generally advises children to turn off electronic devices urges them to play "Stroke Hero," a video game that teaches kids to identify stroke symptoms and summon help, according to a new study. Number games could improve kids' math skills NEW YORK (Reuters Health) - Kids don't need math skills to glance at two groups of black dots and say which group has more dots, but practicing that intuitive task might boost their math scores, according to new research. Gilead to license hepatitis C drug to lower-cost manufacturers in India (Reuters) - Gilead Sciences plans to license its breakthrough hepatitis C drug Sovaldi to a number of Indian generic pharmaceutical manufacturers, allowing for lower-priced sales of the medication in that developing nation, according to the company. Allergy drug firm Circassia seeks $285 million in London IPO LONDON (Reuters) - Circassia, a company developing allergy treatments based on a discovery by scientists at Imperial College in London, plans to raise about 175 million pounds ($285 million) of new funds in a stock market debut to bring its cat allergy vaccine to market. Dutch gene therapy pioneer raises $82 million in U.S. IPO (Reuters) - A small Dutch company behind the Western world's first approved gene therapy priced its shares above the expected range in a U.S. stock offering on Wednesday, showing the current investor appetite for biotechnology. Epidurals may make labor longer than originally thought: study NEW YORK (Reuters Health) - While a shot to relieve labor pains is known to increase the time it takes for women to deliver babies, a new study says the increase may be longer than originally thought. CVS becomes first big U.S. drugstore chain to drop tobacco (Reuters) - CVS Caremark Corp will stop selling tobacco products at its 7,600 stores by October 1, the company said on Wednesday, making it the first national drugstore chain in the United States to take cigarettes off the shelves. Related Video Entrepreneurs turn pollution into plastic Messy winter storm dumps snow, ice on Northeast The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   » MORE NEWSLETTERS

- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend